Dimitrios Nasioudis, MD
Gynecologic Oncology
Accepting new patients
Sees patients age 18 and up
Jordan Center for Gynecologic Cancers
Headshot of Dimitrios Nasioudis, MD
Penn Medicine Provider

About me

  • Assistant Professor of Obstetrics and Gynecology at the Hospital of the University of Pennsylvania

Education and training

  • Medical School: Aristotle University of Thessaloniki
  • Residency: Hospital of the University of Pennsylvania
  • Fellowship: Hospital of the University of Pennsylvania

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
  • Chester County Hospital: Has privileges to treat patients in the hospital.
Dr. Nasioudis is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

Dagher C, Jang M, Nasioudis D De-escalation in stage IC epithelial ovarian cancer: adjuvant treatment. , Int J Gynecol Cancer: 2026,102818. doi: 10.1016/j.ijgc.2025.102818


Jang M, Gysler S, Ko EM, Giuntoli RL 2nd, Latif NA, Kim SH, Nasioudis D Early administration of adjuvant chemotherapy for patients with advanced-stage malignant ovarian germ cell tumors is associated with an overall survival benefit. , Int J Gynecol Cancer: 2026,36(2):102824. doi: 10.1016/j.ijgc.2025.102824


Jang M, Dagher C, Gysler S, Ko EM, Giuntoli RL 2nd, Martin L, Kim SH, Nasioudis D Incidence of ESR1 gene mutations among patients with endometrioid endometrial cancer. , Int J Gynecol Cancer: 2026,36(2):102816. doi: 10.1016/j.ijgc.2025.102816


Mulugeta-Gordon L, Jang M, Dagher C, Nasioudis D Advances in the Surgical Management of Cervical Cancer. , Int J Gynecol Cancer: 2026,18(4):628. doi: 10.3390/cancers18040628


Dagher C, Latif NA, Gysler S, Giuntoli RL 2nd, Kim SH, Ko EM, Nasioudis D Outcomes of patients with metastatic squamous cell carcinoma of the vulva. , Int J Gynecol Cancer: 2026,;36(1):102772. doi: 10.1016/j.ijgc.2025.102772


Huang A, Latif NA, Gysler S, Ko EM, Giuntoli RL 2nd, Kim SH, Nasioudis D Outcomes of the sentinel lymph node mapping algorithm for patients with locally advanced endometrial carcinoma. , Int J Gynecol Cancer: 2025,35(12):102651. doi: 10.1016/j.ijgc.2025.102651


Jang M, Gysler S, Latif NA, Ko EM, Giuntoli RL 2nd, Kim SH, Simpkins F, Nasioudis D Identifying and capitalizing on unique molecular alterations of mucinous ovarian carcinoma for the development of novel therapeutic strategies. , Int J Gynecol Cancer: 2025,63:102008. doi: 10.1016/j.gore.2025.102008


Cucinella G, Zammarrelli WA 3rd, Nasioudis D, Gabrilovich S, Capasso I, Berretta R, Scollo P, Raspagliesi F, Baiocchi G, Barresi G, Pecorino B, Bogani G, Kurnit KC, De Brot L, Lembo A, Maryam S, Fought AJ, McGree ME, Chiantera V, Bosquet JG, Fanfani F, Scambia G, Abu-Rustum NR, Mariani A, Giuntoli R 2nd, Glaser G, Leitao MM Jr Endometrial carcinosarcoma without myoinvasion. , Int J Gynecol Cancer: 2025,35(10):101971. doi: 10.1016/j.ijgc.2025.101971


Caruso G, Ainio C, Fumagalli D, Reynolds EA, Nasioudis D, Mc Gree ME, Fought AJ, Giuntoli RL, Mariani A, Cliby WA Textbook oncologic outcome in endometrial cancer surgery: A quality measure to improve survival and address disparities. , Gynecol Oncol. : 2025,200:33-43. doi: 10.1016/j.ygyno.2025.07.009


Nasioudis D, Gysler S, Latif NA, Giuntoli RL 2nd, Kim SH, Ko EM. Incidence of lymph node metastases in patients with apparent early-stage endometrioid ovarian carcinoma , Int J Gynecol Cancer: 2025